Arcutis Biotherapeutics, Inc.(NasdaqGS:ARQT) added to S&P Biotechnology Select Industry Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.6 USD | -4.64% | -12.24% | +135.29% |
May. 28 | Johnson & Johnson Acquires Experimental Eczema Drug for $1.25 Billion | MT |
May. 15 | Needham Adjusts Price Target on Arcutis Biotherapeutics to $18 From $16, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+135.29% | 880M | |
+19.33% | 125B | |
+13.95% | 108B | |
-3.53% | 24.57B | |
+3.64% | 22.82B | |
-10.39% | 18.19B | |
-41.48% | 16.54B | |
-12.62% | 16.5B | |
+0.99% | 13.39B | |
+21.79% | 11.1B |
- Stock Market
- Equities
- ARQT Stock
- News Arcutis Biotherapeutics, Inc.
- Arcutis Biotherapeutics, Inc.(NasdaqGS: ARQT) added to S&P Biotechnology Select Industry Index